Report overview
This report contains market size and forecasts of Diabetic Therapeutic Drugs in global, including the following market information:
Global Diabetic Therapeutic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Diabetic Therapeutic Drugs Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Diabetic Therapeutic Drugs companies in 2021 (%)
The global Diabetic Therapeutic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Insulin Therapies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetic Therapeutic Drugs include AstraZeneca, Eli Lilly, Merck, Novo Nordisk, Sanofi, Pfizer, Novartis, Perle Biosciences and Sun Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diabetic Therapeutic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetic Therapeutic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Diabetic Therapeutic Drugs Market Segment Percentages, by Type, 2021 (%)
Insulin Therapies
Non-Insulin Therapies
Global Diabetic Therapeutic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Diabetic Therapeutic Drugs Market Segment Percentages, by Application, 2021 (%)
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Global Diabetic Therapeutic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Diabetic Therapeutic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diabetic Therapeutic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Diabetic Therapeutic Drugs revenues share in global market, 2021 (%)
Key companies Diabetic Therapeutic Drugs sales in global market, 2017-2022 (Estimated), (MT)
Key companies Diabetic Therapeutic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Eli Lilly
Merck
Novo Nordisk
Sanofi
Pfizer
Novartis
Perle Biosciences
Sun Pharma
Takeda Pharmaceuticals
F. Hoffmann-La Roche
Belrose Pharma
Mitsubishi Tanabe Pharma
Dong-A ST
Eisai
Arbutus Biopharma
